Neoral and Gingivitis - a phase IV clinical study of FDA data

Summary:

Gingivitis is reported as a side effect among people who take Neoral (cyclosporine), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Prednisolone, and have High blood pressure.

The phase IV clinical study analyzes which people have Gingivitis when taking Neoral. It is created by eHealthMe based on reports of 25,970 people who have side effects when taking Neoral from the FDA, and is updated regularly.

What is Neoral?

Neoral has active ingredients of cyclosporine. It is often used in psoriasis. eHealthMe is studying from 26,084 Neoral users. Check the latest studies of Neoral.

What is Gingivitis?

Gingivitis (inflammation of gums) is found to be associated with 886 drugs and 803 conditions by eHealthMe. Check the latest studies of Gingivitis.

On Jul, 05, 2026

25,970 people reported to have side effects when taking Neoral.
Among them, 21 people (0.08%) have Gingivitis.

Among these 21 people:

How long have people been on Neoral when they have Gingivitis? *

What is the gender of people who have Gingivitis when taking Neoral? *

female: 47.62 %
male: 52.38 %

What is the age of people who have Gingivitis when taking Neoral? *

What are other drugs people take besides Neoral? *

What are other side effects people have besides Gingivitis? *

Fever: 9 people, 42.86%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 28.57%
Infection: 4 people, 19.05%
Gingival Hypertrophy (overgrowth of gums): 4 people, 19.05%
Gingival Bleeding (bleeding gums): 4 people, 19.05%
High Blood Pressure: 4 people, 19.05%
Weight Increased: 3 people, 14.29%
Nausea And Vomiting: 3 people, 14.29%
Kidney Transplant Rejection: 3 people, 14.29%
Kidney Rupture (a kidney state of being broken due to injury): 3 people, 14.29%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 19.05%
Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 3 people, 14.29%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 3 people, 14.29%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 3 people, 14.29%
Dyslipidaemia (abnormal amount of lipids): 3 people, 14.29%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 4.76%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 4.76%
Nausea (feeling of having an urge to vomit): 1 person, 4.76%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 4.76%
Constipation: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Neoral and have Gingivitis?

- Check whether Gingivitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neoral:

Neoral (26,084 reports)

Gingivitis treatments and more:

Gingivitis (9,610 reports)

Browse all side effects of Neoral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingivitis:

Gingivitis (886 drugs)

Browse all the conditions that are associated with Gingivitis:

Gingivitis (803 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Neoral) and Neoral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.